Science Exchange, the world’s leading R&D services marketplace, announced a collaboration with Navitas Life Sciences to offer online access to its suite of service offerings across consulting, support for phase I-IV studies, bioequivalence and bioavailability (BA/BE) studies, and other biosimilars sudies.
Navitas Life Sciences will also provide access to its Functional Service Provider (FSP / BPO) services across regulatory, artwork and labeling, pharmacovigilance / individual case safety reports (PV/ICSR) processing, reporting and signal detection and technology through a proven deliverables/unit pricing model.
Navitas Life Sciences is a global consulting, technology and services provider, whose mission is to enable insights-driven services that will deliver improved outcomes for the Life Sciences Industry.
About Navitas Life Sciences
Navitas Life Sciences is a TAKE Solutions Enterprise, comprised of dedicated life science professionals operating in North and South America, Europe, and Asia Pacific. With a rich legacy of experience in life sciences, they have worked with 9 of the top 10 global pharma companies.
